Market Place
Sourcing Support
All News #Library
Biotech
Ataibeckley To Join Needham Healthcare Conference
14 Apr 2026 //
GLOBENEWSWIRE
BPL-003 Shows Rapid, Durable Effects in Refractory Depression
17 Mar 2026 //
GLOBENEWSWIRE
BPL-003 Phase 3 Program Set for Q2 2026 After FDA Meeting
10 Mar 2026 //
GLOBENEWSWIRE
Ataibeckley Advances BPL-003 For Treatment-Resistant Depression
03 Mar 2026 //
GLOBENEWSWIRE
Ataibeckley`s MDMA Drug Improves Anxiety In Ph. 2 Trial
26 Feb 2026 //
FIERCE BIOTECH
Ataibeckley Updates 2026 Outlook Pre-J.P. Morgan Healthcare Conf
08 Jan 2026 //
GLOBENEWSWIRE
Atai Life, Beckley Psytech Complete Merger for Mental Health
05 Nov 2025 //
GLOBENEWSWIRE
Atai Life Sciences Closes Public Offering, Exercises Full Option
20 Oct 2025 //
GLOBENEWSWIRE
Atai, Beckley Psytech Secure FDA Breakthrough Status For BPL-003
16 Oct 2025 //
GLOBENEWSWIRE
Atai-Partnered Schizophrenia Drug Fails Mid-Stage Trial
28 Jul 2025 //
BIOSPACE
Atai`s Schizophrenia Drug Fails Phase 2 Cognition Test
28 Jul 2025 //
FIERCE BIOTECH
Recognify Life Sciences Updates Phase 2b Trial of Inidascamine
25 Jul 2025 //
GLOBENEWSWIRE
Psilera & Atai Sign Licensing Agreement For DMT Patent Portfolio
20 Feb 2025 //
PR NEWSWIRE
atai Life Sciences to Participate in the 2024 Maxim Healthcare Summit
15 Oct 2024 //
GLOBENEWSWIRE
IntelGenx Court Approves Sale Proposal from atai Life Sciences AG
02 Oct 2024 //
PRESS RELEASE
Atai Life to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit
06 Oct 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.